Disc Medicine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Disc Medicine generated cash of -$73,462,000, which is less than the previous year. Cash used in financing activities reached the amount of $239,379,000 last year. Net change in cash is therefore $165,828,000.
Cash Flow
| 2020 | -32.70M | -22K | 34.24M |
|---|---|---|---|
| 2021 | -27.53M | -68K | 89.92M |
| 2022 | -42.25M | -151K | 148.97M |
| 2023 | -73.46M | -89K | 239.37M |
IRON Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 194.78M | 88.21M | 25.88M | 3.30M |
Operating activities | ||||
Net income | -76.42M | -46.82M | -35.96M | -40.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 100K | 89K | 32K | 322K |
Stock-based compensation expense | 5.53M | 2.08K | 507K | 983K |
| Deferred income tax benefit | 5.53M | 2.08K | 507K | 983K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -3.74M | 526K | 1.31M | -2.40M |
Cash generated by operating activities | -73.46M | -42.25M | -27.53M | -32.70M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -89K | -151K | -68K | -22K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -89K | -151K | -68K | -22K |
Financing activities | ||||
Common Stock Issued | 199.07M | 53.5M | 89.92M | 20.24M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -4.58M | -14M |
Cash used in financing activities | 239.37M | 148.97M | 89.92M | 34.24M |
Net Change In Cash | 165.82M | 106.57M | 62.32M | 1.51M |
Cash at end of period | 360.61M | 194.78M | 88.21M | 4.82M |